-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK - FDA APPROVES JEMPERLI AS FIRST IMMUNOTHERAPY FOR MSI-H/DMMR LOCALLY ADVANCED RECTAL CANCER

Reuters·10/19/2026 16:21:30

Please log in to view news